Acetylcholine Receptor Autoantibodies
Private Acetylcholine Receptor Autoantibodies blood test in London for £290, measuring one autoimmune neuromuscular marker with results in around 6 days.
Turnaround time
6 business days
Biomarkers count
1
Book your test
Choose Service Type
Professional phlebotomist comes to you
+ £{{ home_visit_fee }}
Visit our clinic for your test
{{ clinic_visit_fee > 0 ? '+ £' + clinic_visit_fee : 'Free' }}
Home Visit Details
Home visits require at least 24 hours notice.
Select a clinic: Sorting by distance…
{{ clinicAddress(clinic) }}
{{ clinicAddress(selectedClinic) }}
Select a date
Select an hour
Available time slots: {{ timeSlots.length}}
Overview of the Acetylcholine Receptor Autoantibodies
The Acetylcholine Receptor Autoantibodies blood test is a specialist autoimmune neurology investigation that detects antibodies directed against acetylcholine receptors at the neuromuscular junction.
Acetylcholine receptors play an essential role in communication between nerves and skeletal muscles. When a nerve releases acetylcholine, the chemical binds to these receptors and helps trigger normal muscle contraction.
In autoimmune myasthenia gravis, the immune system can mistakenly produce antibodies against acetylcholine receptors. These antibodies interfere with normal neuromuscular transmission by blocking, damaging or reducing the number of functioning receptors.
The test contains 1 biomarker: Acetylcholine Receptor Autoantibodies.
AChR antibodies are an important diagnostic marker for myasthenia gravis, particularly generalised disease. They are detected in approximately 80–90% of people with generalised myasthenia gravis, although sensitivity is lower in people whose symptoms are confined to the eyes.
This means a positive result can provide strong supporting evidence for autoimmune myasthenia gravis when the symptoms and neurological findings are compatible.
However, a negative result does not completely exclude the condition. Some people with myasthenia gravis have other antibodies, including antibodies to muscle-specific receptor tyrosine kinase (MuSK), while others may remain seronegative on standard antibody testing.
The concentration of AChR antibodies also does not reliably correspond to the severity of symptoms between different people. Results should therefore be interpreted alongside neurological examination, electrophysiological investigations and other specialist tests where appropriate.
What Does the Acetylcholine Receptor Autoantibodies Test Check?
This test measures 1 biomarker.
Acetylcholine Receptor Autoantibodies
Detects autoantibodies directed against acetylcholine receptors at the neuromuscular junction. These antibodies are strongly associated with autoimmune myasthenia gravis and can interfere with normal communication between nerves and skeletal muscles.
Who May Benefit From the Acetylcholine Receptor Autoantibodies Test?
This test may be suitable for people with symptoms or neurological findings suggestive of myasthenia gravis, particularly where muscle weakness fluctuates and becomes more noticeable with repeated activity.
Suspected myasthenia gravis - Acetylcholine receptor antibodies are one of the principal laboratory markers used when autoimmune myasthenia gravis is being investigated.
Drooping eyelids - Ptosis affecting one or both eyes can occur when muscles controlling the eyelids become fatigued.
Unexplained double vision - Weakness affecting the muscles responsible for eye movement can cause diplopia.
Muscle weakness that worsens with activity - Fatigable weakness that becomes more noticeable after repeated muscle use is characteristic of myasthenia gravis.
Muscle strength that improves after rest - Improvement following rest can provide an important clinical clue to impaired neuromuscular transmission.
Difficulty chewing or swallowing - Weakness affecting bulbar muscles can interfere with eating and swallowing.
Changes in speech - Nasal, slurred or increasingly weak speech can occur when muscles involved in speaking become fatigued.
Unexplained weakness of the arms or legs - Generalised myasthenia gravis can affect proximal limb muscles and make activities such as climbing stairs or lifting objects more difficult.
Difficulty holding the head upright - Neck muscle weakness can occur in generalised disease.
Specialist-requested neurological testing - The test can be arranged privately where a neurologist, GP or other healthcare professional has specifically requested AChR antibody measurement.
How to Prepare
Do not stop pyridostigmine, corticosteroids, immunosuppressants or other prescribed medication simply to alter an antibody result unless specifically instructed by the clinician responsible for your treatment.
Clinical history is particularly important because AChR antibody results are interpreted alongside the pattern of weakness and specialist neurological assessment.
Symptoms and Reasons to Consider the Acetylcholine Receptor Autoantibodies Test
You may wish to consider the Acetylcholine Receptor Autoantibodies test when fluctuating or fatigable muscle weakness raises concern about a disorder of neuromuscular transmission.
Drooping of one or both eyelids - Ptosis is a common early feature of myasthenia gravis and may become more noticeable later in the day.
Double vision - Weakness of the eye muscles can cause images to become misaligned, particularly after prolonged visual activity.
Difficulty chewing - Jaw muscles may weaken during a meal, making prolonged chewing increasingly difficult.
Difficulty swallowing - Bulbar muscle weakness can interfere with swallowing food, liquids or saliva.
Nasal or slurred speech - Speech may become weaker or less clear after prolonged talking.
Weakness in the shoulders or upper arms - Activities such as lifting objects, washing hair or reaching overhead may become more difficult.
Weakness in the hips or legs - Climbing stairs, rising from a chair or walking longer distances may become progressively harder.
Difficulty holding the head up - Weakness of the neck muscles can make maintaining head position difficult.
Symptoms that worsen later in the day - Myasthenic weakness frequently becomes more noticeable after repeated activity and improves following rest.
These symptoms can occur with many neurological, muscular, metabolic and systemic conditions and do not by themselves confirm myasthenia gravis.
A negative AChR antibody result also does not completely exclude myasthenia gravis, particularly where symptoms are confined to the eyes or where another antibody subtype is involved.
Increasing difficulty breathing, severe swallowing difficulty, inability to manage saliva, rapidly worsening weakness or significant respiratory symptoms may indicate a myasthenic crisis and require urgent medical assessment rather than waiting for routine private test results.
How to Book Your Acetylcholine Receptor Autoantibodies Test
Booking your Acetylcholine Receptor Autoantibodies test with London Blood Tests is simple and designed to fit around your schedule.
Choose the Acetylcholine Receptor Autoantibodies
Select the Acetylcholine Receptor Autoantibodies test online and review the included autoimmune neuromuscular biomarker before booking.
Select your sample collection option
Choose an in-clinic blood draw (+£35) or a home or hotel phlebotomy visit (+£60) where a qualified phlebotomist collects your sample.
Attend your appointment
A trained professional will collect your blood sample safely and efficiently at the clinic or during your arranged home or hotel visit.
Laboratory analysis
Your sample is sent to the laboratory, where Acetylcholine Receptor Autoantibodies are assessed using specialist autoimmune neurology testing.
Receive your results securely
Your results are sent securely by email, ready to review yourself or discuss with a GP, neurologist or other suitably qualified healthcare professional.
When Will I Receive My Results?
The expected turnaround time for the Acetylcholine Receptor Autoantibodies test is approximately 6 days after your sample arrives at the laboratory.
Results are sent securely by email once specialist laboratory analysis and authorisation are complete. Turnaround therefore begins when the laboratory receives your sample rather than necessarily from the time your blood is collected.
Specialist autoimmune testing may occasionally require repeat analysis, confirmation or additional laboratory review, which can extend the expected turnaround.
Understanding Your Results
Your Acetylcholine Receptor Autoantibodies result indicates whether antibodies directed against acetylcholine receptors have been detected according to the laboratory method and reporting criteria used.
A positive result provides strong supporting evidence for autoimmune myasthenia gravis when compatible symptoms and neurological findings are present.
AChR antibodies are detected in approximately 80–90% of people with generalised myasthenia gravis.
Sensitivity is lower in purely ocular myasthenia gravis, where symptoms are limited primarily to the eyelids and eye muscles. A negative result therefore does not completely exclude the condition.
Where symptoms remain strongly suggestive despite a negative result, a neurologist may consider additional antibody testing, including MuSK antibodies, clustered AChR antibodies or other specialist neuromuscular investigations.
AChR antibody concentration does not reliably predict disease severity between different people.
For an individual patient, changes may sometimes occur alongside changes in disease activity, but routine repeated antibody measurement is not usually considered a substitute for clinical monitoring.
Diagnosis of myasthenia gravis may also involve neurological examination, repetitive nerve stimulation, single-fibre electromyography and imaging of the thymus depending on the clinical circumstances.
Results should therefore be interpreted within the wider neurological context rather than as a standalone diagnosis.
Why Book With London Blood Tests?
Private AChR antibody testing in London - Access specialist Acetylcholine Receptor Autoantibodies testing through London Blood Tests.
Targeted myasthenia gravis investigation - Measure AChR antibodies independently when autoimmune neuromuscular disease is being investigated.
Relevant to fatigable muscle weakness - Testing can provide important supporting information where weakness worsens with activity and improves with rest.
Useful for ocular and generalised symptoms - AChR antibody testing can form part of the investigation of ptosis, double vision and more generalised muscle weakness.
Specialist autoimmune laboratory analysis - Your sample is processed using dedicated testing for acetylcholine receptor antibodies.
Clinic and home visit options - Choose an in-clinic blood draw or arrange home or hotel phlebotomy depending on location and availability.
Secure results by email - Receive your authorised laboratory result securely once analysis is complete.
Clear pricing before booking - The Acetylcholine Receptor Autoantibodies test is priced at £290, with sample collection charges shown separately.
Private Acetylcholine Receptor Autoantibodies Blood Test in London
London Blood Tests provides the Acetylcholine Receptor Autoantibodies blood test in London for people requiring specialist investigation of suspected autoimmune myasthenia gravis.
The test costs £290 and measures one biomarker: Acetylcholine Receptor Autoantibodies.
AChR antibodies interfere with normal signalling between nerves and skeletal muscles and are strongly associated with generalised myasthenia gravis.
Clinic appointments are available alongside home and hotel phlebotomy depending on location and availability, providing flexible options for people looking for a private AChR antibody blood test in London or specialist myasthenia gravis testing near them.
A positive result provides important supporting information but should be interpreted alongside symptoms and specialist neurological assessment. A negative result does not completely exclude myasthenia gravis.